Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib.

About 75% of patients with newly diagnosed chronic phase (CP) chronic myeloid leukemia (CML) treated initially with imatinib achieve complete cytogenetic remission (CCyR),1 and imatinib also induces Ph negativity, though less often, in patients treated in advanced phases of CML. Patients in CCyR may however still have as many as 1010 leukemia cells in their body,2 and in CML the quantity of suc...

متن کامل

Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy

BACKGROUND/AIMS Sorafenib is currently the sole molecular targeted agent that improves overall survival in advanced hepatocellular carcinoma (HCC). Despite the efficacy of sorafenib, the response rate varies in patients with advanced HCC. We retrospectively analyzed a series of Korean patients with advanced HCC with complete remission (CR) after sorafenib therapy. METHODS In total, 523 patien...

متن کامل

Advancing the management of double hit lymphoma

Double hit lymphoma (DHL), commonly defined as an aggressive B cell non-Hodgkin lymphoma (NHL) harboring rearrangement of MYC as well as BCL2 and/or BCL6, has recently been formally categorized as “High grade B-cell lymphoma [HGBL], with rearrangements of MYC and BCL2 and/or BCL6” as per the 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms. Patients with...

متن کامل

first complete remission versus other- than- first complete remission in acute myelogenous leukemia with allogeneic hematopoietic stem cell transplantation

introduction: the traditional goal of the treatment of acute myelogenous leukemia is to produce and maintain a complete remission (cr).the difference in survival time was entirely attributable to the duration of time spent in cr .in this study, the outcome of aml patients with allogeneic hsct in cr1 versus other than cr1 was compared. patients and methods: since march 1991 until november 2008, ...

متن کامل

Double hit lymphoma presenting as haemophagocytic lymphohistiocytosis.

Rivera XI, et al. BMJ Case Rep 2017. doi:10.1136/bcr-2017-220401 Description A 67-year-old woman with history of severe rheumatoid arthritis and use of multiple biologics including infliximab, tocilizumab and abatacept presented with fever of 39.1°C and severe pancytopenia (white blood cell count (WBC)=1.0×10/L, absolute neutrophil count (ANC)=0.55×10/L, haemoglobin=8.7 g/ dL, platelets=46×10/L...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Clinical Oncology

سال: 2017

ISSN: 0732-183X,1527-7755

DOI: 10.1200/jco.2017.72.2157